Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 7/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 7/20 | 0.35 |
| ▸ | GUCY1A1 | Q02108 | 3/20 | 0.34 |
| ▸ | GUCY1B1 | Q02153 | 3/20 | 0.34 |
| ▸ | PDE5A | O76074 | 8/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15937438 | 0.93 | GRIN1 (0.34) | GRIN1GRIN2BGUCY1A1GUCY1B1PDE5A | |
| Acetic Acid SCHEMBL15937793 | 0.85 | PDE5A (0.33) | GUCY1A1GUCY1B1PDE5A | |
| SCHEMBL19264469 | 0.84 | GRIN1 (0.36) | GRIN1GRIN2BPDE5A | |
| Acetic Acid SCHEMBL15937721 | 0.84 | GRIN1 (0.35) | GRIN1GRIN2BGUCY1A1GUCY1B1PDE5A | |
| Acetic Acid SCHEMBL15633156 | 0.84 | PDE5A (0.48) | GRIN1GRIN2BPDE5A | |
| SCHEMBL14488217 | 0.82 | GRIN1 (0.33) | GRIN1GRIN2BPDE5A | |
| SCHEMBL19244698 | 0.81 | GRIN1 (0.34) | GRIN1GRIN2BGUCY1A1GUCY1B1PDE5A | |
| Acetic Acid SCHEMBL428284 | 0.81 | PDE5A (0.48) | GUCY1A1GUCY1B1PDE5A | |
| Acetic Acid SCHEMBL16244961 | 0.81 | PDE5A (0.34) | GRIN1GRIN2BGUCY1A1GUCY1B1PDE5A | |
| Acetic Acid SCHEMBL16244815 | 0.81 | PTGDR2 (0.40) | GUCY1A1GUCY1B1PDE5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140228366-A1 | HETEROARYL-SUBSTITUTED PYRAZOLOPYRIDINES AND USE THEREOF AS SOLUBLE GUANYLATE CYCLASE STIMULATORS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140228366-A1 | HETEROARYL-SUBSTITUTED PYRAZOLOPYRIDINES AND USE THEREOF AS SOLUBLE GUANYLATE CYCLASE STIMULATORS | GUCY1A2, GUCY1B2, GUCY1B1 | GRIN1 3030/4885GRIN2B 3045/4885GUCY1A1 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.